Get the Stockscreener App
2.54
0.40%
0.01
After Hours:
2.44
-0.10
-3.94%
Alzamend Neuro Inc stock is traded at $2.54, with a volume of 139.26K.
It is up +0.40% in the last 24 hours and up +0.40% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.53
Open:
$2.52
24h Volume:
139.26K
Relative Volume:
1.18
Market Cap:
$7.98M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-0.4548
EPS:
-5.5853
Net Cash Flow:
$-8.09M
1W Performance:
+3.67%
1M Performance:
+0.40%
6M Performance:
-57.88%
1Y Performance:
-82.84%
1-Day Range:
$2.3801
$2.55
1-Week Range:
$2.30
$2.68
52-Week Range:
$2.06
$15.21
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.54 | 9.62M | 0 | -6.24M | -8.09M | -5.5853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
Comparing Alzamend Neuro Inc. in custom built stock radarsWeekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
How to build a dashboard for Alzamend Neuro Inc. stockVolume Spike & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-11-03 07:34:53 - newser.com
Historical volatility pattern of Alzamend Neuro Inc. visualizedWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 2025Insider Buying & Technical Confirmation Trade Alerts - newser.com
How Alzamend Neuro Inc. stock reacts to job market dataWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-11-03 04:54:44 - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisionsTrade Entry Summary & Community Verified Watchlist Alerts - newser.com
What earnings revisions data tells us about Alzamend Neuro Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - newser.com
Will Alzamend Neuro Inc. stock remain a Wall Street favoritePortfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Will Alzamend Neuro Inc. stock pay special dividendsWeekly Trade Review & Community Consensus Stock Picks - newser.com
Is Alzamend Neuro Inc. stock cheap compared to fundamentalsWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Will Alzamend Neuro Inc. stock go up soonJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Can Alzamend Neuro Inc. stock outperform in 2025 bull marketTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Why Alzamend Neuro Inc. stock attracts high net worth investorsRate Hike & Fast Entry Momentum Trade Alerts - newser.com
Multi asset correlation models including Alzamend Neuro Inc.July 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Is Alzamend Neuro Inc. stock supported by innovation pipelineRate Cut & Safe Capital Growth Stock Tips - newser.com
Alzamend Neuro Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
A activityJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Predicting Alzamend Neuro Inc. trend using moving averagesMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
What to do if you’re stuck in Alzamend Neuro Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
Can Alzamend Neuro Inc. stock resist sector downturns2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
How currency fluctuations impact Alzamend Neuro Inc. stockEntry Point & Safe Capital Growth Trade Ideas - newser.com
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):